This behavior is prevalent among multiple tumor types including GBM, as elevated GRP78 levels in gliomas compared to normal human astrocytes have been repeatedly demonstrated and confirmed via immunohistochemistry, immunoblotting, and proteomic approaches in patient samples (10, 33, 34). This evidence concerns the gene HSPA5 and neoplasm.